BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized pill dose could sharply cut breast cancer risk
Prevention Recruiting nowThis study is testing a personalized approach to using the drug tamoxifen to prevent breast cancer in premenopausal women at higher-than-average risk. Researchers want to see if starting with a low dose and increasing it only for women who don't show a good initial response on th…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Apr 04, 2026 06:51 UTC
-
New drugs tested to stop breast cancer before it starts
Prevention Recruiting nowThis study is testing two medications, acolbifene and a low dose of tamoxifen, to see if they can help prevent breast cancer in premenopausal women who are at high risk for developing it. About 80 participants will take one of the pills daily for six months. Researchers will chec…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Apr 04, 2026 06:50 UTC
-
Can a pill and fish oil stop breast cancer before it starts?
Prevention Recruiting nowThis study is testing whether a low dose of the drug tamoxifen, taken with or without high-dose omega-3 fish oil supplements, can help prevent breast cancer in women at high risk. It is for overweight or obese postmenopausal women who have specific risk factors, like a family his…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Mar 25, 2026 14:07 UTC
-
Personalized genetics could transform breast cancer prevention for minority women
Knowledge-focused Recruiting nowThis study aims to see if adding a genetic risk score to standard breast cancer risk assessments helps African American and Hispanic women make more informed decisions about screening and prevention. Researchers will follow 50 women with elevated breast cancer risk for 10 years t…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC